Compare RXST & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RXST | CRON |
|---|---|---|
| Founded | 1997 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 513.1M | 961.2M |
| IPO Year | 2021 | N/A |
| Metric | RXST | CRON |
|---|---|---|
| Price | $12.73 | $3.24 |
| Analyst Decision | Hold | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $11.30 | N/A |
| AVG Volume (30 Days) | 837.8K | ★ 2.7M |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | ★ $142,085,000.00 | $132,357,000.00 |
| Revenue This Year | N/A | $19.67 |
| Revenue Next Year | $4.18 | $30.56 |
| P/E Ratio | ★ N/A | $34.73 |
| Revenue Growth | 10.75 | ★ 19.00 |
| 52 Week Low | $6.32 | $1.60 |
| 52 Week High | $39.37 | $3.27 |
| Indicator | RXST | CRON |
|---|---|---|
| Relative Strength Index (RSI) | 70.03 | 83.17 |
| Support Level | $11.84 | $2.40 |
| Resistance Level | $13.22 | $2.92 |
| Average True Range (ATR) | 0.64 | 0.15 |
| MACD | 0.10 | 0.07 |
| Stochastic Oscillator | 84.76 | 98.35 |
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.